GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 1CM Inc (XCNQ:EPIC) » Definitions » COGS-to-Revenue

1CM (XCNQ:EPIC) COGS-to-Revenue : 0.80 (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is 1CM COGS-to-Revenue?

1CM's Cost of Goods Sold for the three months ended in Feb. 2024 was C$10.58 Mil. Its Revenue for the three months ended in Feb. 2024 was C$13.29 Mil.

1CM's COGS to Revenue for the three months ended in Feb. 2024 was 0.80.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 1CM's Gross Margin % for the three months ended in Feb. 2024 was 20.43%.


1CM COGS-to-Revenue Historical Data

The historical data trend for 1CM's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

1CM COGS-to-Revenue Chart

1CM Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.43 1.51 0.78

1CM Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.80 0.78 0.80 0.80

1CM COGS-to-Revenue Calculation

1CM's COGS to Revenue for the fiscal year that ended in Aug. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=27.732 / 35.341
=0.78

1CM's COGS to Revenue for the quarter that ended in Feb. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=10.577 / 13.292
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


1CM  (XCNQ:EPIC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

1CM's Gross Margin % for the three months ended in Feb. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 10.577 / 13.292
=20.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


1CM COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 1CM's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


1CM (XCNQ:EPIC) Business Description

Traded in Other Exchanges
Address
625 Cochrane Drive, Suite 802, Markham, ON, CAN, L3R9R9
1CM Inc is a multi-jurisdictional cannabis company focused on it's retail customers and technology to democratize cannabis markets. The Company is focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions.

1CM (XCNQ:EPIC) Headlines

No Headlines